Moreover, variants found in subjects at risk for GC, particularly in FDRs and recently findings of novel mutations in sporadic GC patients in Chinese population [59], invite to screen for CDH1 genetic alterations in addition to other risk factors, to define a high-risk group of patients that would benefit from an early GC diagnosis. Here, CDH1 is linked to gastric cancer.